Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 01:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.37 Insider Own4.90% Shs Outstand31.15M Perf Week37.44%
Market Cap99.87M Forward P/E- EPS next Y-0.45 Insider Trans7.46% Shs Float30.44M Perf Month18.18%
Income-11.60M PEG- EPS next Q-0.11 Inst Own16.39% Short Float1.77% Perf Quarter-1.58%
Sales0.00M P/S- EPS this Y-34.37% Inst Trans6.48% Short Ratio6.33 Perf Half Y-30.20%
Book/sh0.74 P/B4.23 EPS next Y-4.65% ROA-44.64% Short Interest0.54M Perf Year-1.89%
Cash/sh0.73 P/C4.30 EPS next 5Y- ROE-45.98% 52W Range2.14 - 5.13 Perf YTD-19.59%
Dividend Est.- P/FCF- EPS past 5Y16.79% ROI-48.89% 52W High-39.18% Beta0.92
Dividend TTM- Quick Ratio14.40 Sales past 5Y-55.51% Gross Margin77.14% 52W Low45.45% ATR (14)0.18
Dividend Ex-Date- Current Ratio14.40 EPS Y/Y TTM-4.91% Oper. Margin0.00% RSI (14)72.32 Volatility8.78% 6.25%
Employees5 Debt/Eq0.01 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-32.97% Payout- Rel Volume3.81 Prev Close2.77
Sales Surprise- EPS Surprise9.09% Sales Q/Q-100.00% EarningsJun 07 Avg Volume85.00K Price3.12
SMA2028.71% SMA5019.47% SMA200-6.67% Trades Volume181,864 Change12.63%
Date Action Analyst Rating Change Price Target Change
Dec-23-22Initiated Chardan Capital Markets Buy $8
Apr-12-21Initiated H.C. Wainwright Buy $11
Today 08:30AM
Jun-24-24 08:45AM
Jun-04-24 09:52PM
May-28-24 06:10AM
07:30AM Loading…
May-21-24 07:30AM
May-09-24 04:21AM
May-08-24 08:25AM
May-07-24 09:15AM
May-06-24 08:05AM
Apr-30-24 07:45AM
Apr-18-24 08:20AM
Mar-14-24 08:45AM
Mar-11-24 08:00AM
Feb-12-24 07:30AM
08:50AM Loading…
Jan-29-24 08:50AM
Jan-23-24 07:55AM
Jan-16-24 08:47AM
Jan-10-24 09:00AM
Dec-14-23 07:15AM
Dec-11-23 12:26PM
Dec-06-23 06:00PM
Nov-27-23 08:30AM
Oct-31-23 08:30AM
Oct-30-23 07:38AM
Oct-23-23 08:30AM
Oct-20-23 05:36AM
Oct-13-23 09:55AM
11:08AM Loading…
Oct-12-23 11:08AM
Oct-03-23 08:30AM
Sep-21-23 12:00PM
Sep-19-23 08:30AM
Sep-11-23 10:11PM
Aug-31-23 08:30AM
Aug-28-23 08:30AM
Aug-14-23 08:30AM
Aug-10-23 09:30AM
Aug-07-23 08:30AM
Jul-27-23 08:30AM
Jul-24-23 10:44AM
Jul-21-23 12:05PM
Jul-14-23 10:56AM
Jul-13-23 07:08AM
Jul-11-23 10:24AM
Jul-07-23 10:42AM
Jun-22-23 12:00PM
May-22-23 08:30AM
Apr-25-23 09:40AM
Apr-18-23 11:43AM
Apr-17-23 03:27PM
Apr-14-23 08:50AM
Apr-03-23 08:47AM
Mar-27-23 08:30AM
Mar-13-23 08:30AM
Mar-02-23 08:30AM
Feb-27-23 08:30AM
Feb-21-23 08:30AM
Jan-24-23 07:59AM
Dec-28-22 10:39AM
Dec-19-22 08:30AM
Dec-08-22 08:30AM
Nov-08-22 08:30AM
Oct-31-22 08:30AM
Oct-26-22 08:30AM
Oct-25-22 07:51AM
Oct-10-22 08:30AM
Sep-12-22 08:30AM
Aug-31-22 08:30AM
Aug-15-22 08:30AM
Jul-21-22 08:30AM
Jun-21-22 08:30AM
May-18-22 06:16AM
May-05-22 08:30AM
May-02-22 09:40AM
Apr-28-22 08:30AM
Apr-06-22 08:30AM
Mar-30-22 12:45PM
Mar-17-22 08:30AM
Jan-25-22 08:30AM
Jan-24-22 08:30AM
Dec-16-21 08:30AM
Dec-09-21 04:38AM
Dec-08-21 07:47AM
Dec-07-21 08:30AM
Oct-26-21 08:35AM
Oct-06-21 08:30AM
Oct-01-21 08:30AM
Sep-27-21 02:01PM
Sep-14-21 08:31AM
Sep-08-21 08:30AM
Sep-07-21 08:30AM
Aug-31-21 11:08AM
Aug-30-21 08:30AM
Aug-25-21 03:14PM
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Titterton Lewis H jrDirectorJun 14 '24Buy2.684,00010,720860,612Jun 18 09:22 AM
Titterton Lewis H jrDirectorJun 13 '24Buy2.704051,094856,612Jun 14 09:56 AM
Titterton Lewis H jrDirectorJun 11 '24Buy2.667,10218,891856,207Jun 12 11:18 AM
Titterton Lewis H jrDirectorJun 10 '24Buy2.60330858849,105Jun 12 11:18 AM
KUMAR AMITChief Executive OfficerJun 07 '24Buy2.4125,00060,250516,925Jun 07 10:57 AM
Titterton Lewis H jrDirectorJun 07 '24Buy2.5210,73827,060848,775Jun 10 10:03 AM
Catelani MichaelPresident, COO, & CFOJun 07 '24Buy2.406,25015,00035,211Jun 07 12:24 PM
Titterton Lewis H jrDirectorApr 09 '24Buy3.2815,00949,230838,037Apr 10 09:44 AM
KUMAR AMITChief Executive OfficerMar 15 '24Buy3.2230,00096,600491,925Mar 15 10:49 AM
Baskies Arnold MDirectorMar 15 '24Buy3.6310,00036,300110,000Mar 15 02:15 PM
Titterton Lewis H jrDirectorOct 10 '23Option Exercise2.5816,00041,200823,028Oct 11 10:35 AM
KUMAR AMITChief Executive OfficerJul 31 '23Sale3.5711,80042,126461,925Jul 31 06:34 PM
KUMAR AMITChief Executive OfficerJul 28 '23Option Exercise2.5840,000103,000502,100Jul 31 06:34 PM
Titterton Lewis H jrDirectorJul 27 '23Option Exercise2.58120,000309,000894,070Jul 31 06:36 PM
Catelani MichaelPresident, COO & CFOJul 20 '23Buy3.645,50020,02026,655Jul 21 10:06 AM